Quick Takeaways
- This page summarizes David Hung's Form 4 filing for Nuvation Bio Inc. (NUVB).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 08 Apr 2025, 21:30.
David Hung - 04 Apr 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)
- Signature
- /s/ Stephen Dang, Attorney-in-Fact
- Issuer symbol
- NUVB
- Transactions as of
- 04 Apr 2025
- Net transactions value
- +$820,220
- Form type
- 4
- Filing time
- 08 Apr 2025, 21:30:51 UTC
- Previous filing
- 04 Mar 2025
- Next filing
- 04 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"David Hung filed Form 4 for Nuvation Bio Inc. (NUVB) on 08 Apr 2025."
What Changed
- Previous filing in this sequence was filed on 04 Mar 2025.
- Current net transaction value: +$820,220.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
NUVB
transaction
Class A Common Stock
Purchase
- Transaction value
- $332,720
- Shares
- +200,000
- Change %
- +0.34%
- Price
- $1.66
- Shares after
- 58,481,054
- Date
- 04 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
NUVB
transaction
Class A Common Stock
Purchase
- Transaction value
- $487,500
- Shares
- +300,000
- Change %
- +0.51%
- Price
- $1.62
- Shares after
- 58,781,054
- Date
- 07 Apr 2025
- Ownership
- Direct
- Footnotes
- F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.6499 to $1.6699, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |
| F2 | ) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.78, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |